MUMBAI/HONG KONG, Aug 28 (Reuters) - Indian drug maker Dr. Reddy’s Laboratories Ltd. (REDY.BO: Quote, Profile, Research) (RDY.N: Quote, Profile, Research) plans to sell up to $300 million in an overseas share sale to fund a recent acquisition, sources familiar with the matter said on Monday.
